Share:
Peer-Reviewed Publication
Gut Microbes2026;18(1):2661854.December 31, 2026Journal Article

Glucagon-like peptide-1: a critical link between gut microbiota dysbiosis and degenerative musculoskeletal diseases.

Wenxing Yang1,2,3, Cong Hao1,2,3, Ning Wang1,2,3, Jie Xie1,2,3, Bin Zhou2,3, Zidan Yang2,3, Aojie Zheng1,2,3, Jie Wei1,2,3,4,5, Changjun Li2,3,6, Cen Xie7,8, Hui Li1,2,3, Guanghua Lei1,2,3,5,9, Chao Zeng1,2,3,4,9
1Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, People's Republic of China.
2Key Laboratory of Aging-related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Xiangya Hospital, Central South University, Changsha, People's Republic of China.
3Hunan Key Laboratory of Joint Degeneration and Injury, Changsha, People's Republic of China.
4Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, People's Republic of China.
5FuRong Laboratory, Changsha, Hunan, People's Republic of China.
6Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital, Central South University, Changsha, People's Republic of China.
7State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People's Republic of China.
8School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.
9National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, People's Republic of China.

Abstract

Degenerative musculoskeletal diseases are characterized by the progressive loss of structural integrity and functional capacity in muscles, bones, joints, and other related tissues. These conditions primarily include osteoarthritis, osteoporosis, sarcopenia, and intervertebral disc degeneration. These diseases progress gradually, leading to chronic pain, impaired mobility, and a significantly elev…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.